• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 Sep 16;S1201-9712(20)30745-1.
doi: 10.1016/j.ijid.2020.09.028. Online ahead of print.
Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil


Rafael V Picon[SUP] 1 [/SUP], Ion? Carreno[SUP] 2 [/SUP], Andr? Anjos da Silva[SUP] 3 [/SUP], M?rcio Mossmann[SUP] 4 [/SUP], Gabriela Laste[SUP] 5 [/SUP], Guilherme de Campos Domingues[SUP] 4 [/SUP], Lara Faria Fernandes Heringer[SUP] 4 [/SUP], Brenda Rodrigues Gheno[SUP] 4 [/SUP], Leticia Le?o Alvarenga[SUP] 4 [/SUP], Magali Conte[SUP] 6 [/SUP]



Affiliations

Abstract

Objectives: To assess population-based prevalence, risk factors, hospitalization, and infection fatality rates (IFR) associated with COVID-19.
Methods: We conducted two household surveys among the non-institutionalized adult population from May 30 to June 17, 2020, in Lajeado, an 84,000-inhabitants industrial city in southern Brazil. Primary outcome was prevalence of SARS-CoV-2 infection. Secondary outcomes were COVID-19 hospitalizations and deaths occurring up to June 20, 2020. We summarized prevalence rates across surveys with meta-analysis. We assessed age-range IFR and hospitalization rate and regressed these rates over age strata using nonlinear coefficients of determination (R[SUP]2[/SUP]).
Results: Summarized overall prevalence was 3.40% (95% CI, 2.74 to 4.18), 34% lower in elderly ≥60 years-old. IFR ranged from 0.08% (0.06 to 0.11) to 4.63% (2.93 to 7.84) in individuals 20 to 39 years-old and ≥60 years-old, respectively. R[SUP]2[/SUP] for exponential age-dependent hospitalization rate and IFR were 0.98 and 0.93 (both p-values <0.0001), respectively.
Conclusions: This is the first population-based study in Brazil to estimate COVID-19 prevalence, hospitalization and fatality rates per age stratum. Rates were largely age-dependent. Household contacts and MPP workers are at higher risk of infection. Our findings are valuable for health-policy making and resource allocation to mitigate the pandemic.

Keywords: COVID-19; SARS-CoV-2; hospitalization; infection fatality rate; prevalence.
 
Back
Top Bottom